A promising structural magnetic resonance imaging assessment in patients with preclinical cognitive decline and diabetes mellitus

Journal of Cellular Physiology
Yulan DongJincai Liu

Abstract

Subjective cognitive decline (SCD) is frequently reported in diabetic patients. Diabetes mellitus (DM) is associated with changes in the microstructure of the brain arise in diabetic patients, including changes in gray matter volume (GMV). However, the underlying mechanisms of changes in GMV in DM patients with cognitive impairment remain uncertain. Here, we present an overview of amyloid-β-dependent cognitive impairment in DM patients with SCD. Moreover, we review the evolving insights from studies on the GMV changes in GMV and cognitive dysfunction to which provide the mechanisms of cognitive impairment in T2DM. Ultimately, the novel structural magnetic resonance imaging (MRI) protocol was used for detecting neuroimaging biomarkers that can predict the clinical outcomes in diabetic patients with SCD. A reliable MRI protocol would be helpful to detect neurobiomarkers, and to understand the pathological mechanisms of preclinical cognitive impairment in diabetic patients.

References

Sep 1, 1982·The American Journal of Psychiatry·B ReisbergT Crook
Jan 27, 2004·Brain Research. Cognitive Brain Research·Audrey DuarteRobert T Knight
Aug 18, 2004·Neurobiology of Aging·Leyla deToledo-MorrellD A Turner
Aug 20, 2005·Lancet Neurology·Mei Sian Chong, Suresh Sahadevan
Sep 1, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Latha DeviHindupur K Anandatheerthavarada
Sep 2, 2008·Proceedings of the National Academy of Sciences of the United States of America·Camilla A Hansson PetersenMaria Ankarcrona
Apr 1, 2007·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Marieke van OijenMonique M B Breteler
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jia YaoRoberta Diaz Brinton
Aug 12, 2009·Neurology·C R McDonaldUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Feb 17, 2010·Nature Reviews. Neurology·Kaj BlennowHenrik Zetterberg
Jun 12, 2010·Neurobiology of Aging·S K MadsenUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Sep 28, 2010·Journal of the Neurological Sciences·Manon BrundelUNKNOWN Utrecht Diabetic Encephalopathy Study Group
May 11, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Deborah A Levine, Kenneth M Langa
Sep 22, 2011·Immunity & Ageing : I & a·Sergio DavinelliGiovanni Scapagnini
Oct 25, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Erik S MusiekJohn A Detre
Feb 14, 2013·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Silvia MangiaIvan Tkáč
Apr 5, 2013·Frontiers in Aging Neuroscience·Shannon L RisacherUNKNOWN Alzheimer's Disease Neuroimaging Initiative (ADNI)†
May 2, 2013·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Jwa-Kyung KimYoung Rim Song
Aug 14, 2013·Diabetes Care·Chris MoranVelandai Srikanth
Oct 25, 2013·International Review of Psychiatry·Esther WaltonStefan Ehrlich
Oct 26, 2013·Current Alzheimer Research·Mark McEvoyJohn Attia
Oct 31, 2013·Diabetes·Matthew J MarzelliUNKNOWN Diabetes Research in Children Network (DirecNet)
Nov 21, 2013·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Zhiye ChenLin Ma
Jan 15, 2014·Journal of Clinical and Experimental Neuropsychology·Po Lai YauAntonio Convit
Mar 15, 2014·Clinics·Alessandro Ferrari JacintoRicardo Nitrini
May 7, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Frank JessenUNKNOWN Subjective Cognitive Decline Initiative (SCD-I) Working Group
Jul 16, 2014·Journal of Alzheimer's Disease : JAD·Natalia García-CasaresPedro González-Santos
Jul 24, 2014·Diabetes·Chris MoranVelandai Srikanth
Jul 31, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Tomas HajekMartin Alda
Dec 5, 2014·Journal of Alzheimer's Disease : JAD·Dix MeiberthFrank Jessen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Related Papers

Current Diabetes Reports
Lindsay A ZillioxJames W Russell
Dementia and Geriatric Cognitive Disorders
Jeroen de BresserUtrecht Diabetic Encephalopathy Study group
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Manon BrundelGeert Jan Biessels
Journal of the Neurological Sciences
K KatulskaA Wykrętowicz
© 2022 Meta ULC. All rights reserved